Can your allergy pills fight COVID? massive study investigates
NCT ID NCT05504057
Summary
This study aims to see if people who already take antihistamines (common allergy drugs) or amantadine (a Parkinson's drug) have milder COVID-19. Researchers will track over 140,000 people to compare rates of hospitalization, survival, and long-term symptoms between those on these drugs and the general population. The goal is to understand if these existing medications can help control the severity of COVID-19.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital de Terrassa
RECRUITINGTerrassa, Barcelona, 08227, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital of Terrassa
RECRUITINGTerrassa, Barcelona, 08227, Spain
Contact
Conditions
Explore the condition pages connected to this study.